Eraña, Hasier
Díaz-Domínguez, Carlos M.
Charco, Jorge M.
Vidal, Enric
González-Miranda, Ezequiel
Pérez-Castro, Miguel A.
Piñeiro, Patricia
López-Moreno, Rafael
Sampedro-Torres-Quevedo, Cristina
Fernández-Veiga, Leire
Tasis-Galarza, Juan
Lorenzo, Nuria L.
Santini-Santiago, Aileen
Lázaro, Melisa
García-Martínez, Sandra
Gonçalves-Anjo, Nuno
San-Juan-Ansoleaga, Maitena
Galarza-Ahumada, Josu
Fernández-Muñoz, Eva
Giler, Samanta
Valle, Mikel
Telling, Glenn C.
Geijó, Mariví
Requena, Jesús R.
Castilla, Joaquín http://orcid.org/0000-0002-2216-1361
Funding for this research was provided by:
Ministerio de Economía y Competitividad, Gobierno de España (PID2021-122201OB-C21, PID2021-1222010B-C22, PID2020-117465GB-I00)
European Regional Development Fund and Instituto de Salud Carlos III (AC21_2/00024)
Article History
Received: 29 June 2023
Accepted: 20 August 2023
First Online: 7 September 2023
Declarations
:
: Authors have read the journal’s policy and have the following competing interests that need to be declared: Authors Hasier Eraña and Jorge M. Charco are employed by the commercial company ATLAS Molecular Pharma SL. This does not alter our adherence to all Journal policies on sharing data and materials and did not influence in any way the work reported in this manuscript.